← FDA Drug Approvals (Drugs@FDA)
RIBAVIRIN
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: NAVINTA LLC · Approved 2016-10-06
Drug application
- FDA Application #
ANDA207366- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- RIBAVIRIN
- Generic name
- RIBAVIRIN
- Active ingredients
- RIBAVIRIN
- Dosage form
- FOR SOLUTION
- Route
- INHALATION
- Marketing status
- Discontinued
- Sponsor
- NAVINTA LLC
- Manufacturer
- Navinta LLC
- First approval
- 2016-10-06
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown